| Erlotinib investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 144show all (up to 200) |
|---|
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 168 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 168 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasmcancer 30 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasmcancer 29 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Squamous Non-Small Cell Carcinoma 25 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 22 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 22 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Head and Neck Neoplasm 15 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Head and Neck Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasm 10 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 9 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colorectal Neoplasmsubtype 9 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colorectal Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hepatocellular Carcinoma 6 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hepatocellular Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Neoplasm 6 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pancreatic Adenocarcinomasubtype 6 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Pancreatic Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brain Neoplasm 5 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Brain Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Renal Cell Carcinoma 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Renal Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |